These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2753071)

  • 1. Effect of age on the pharmacokinetics of dipyrone.
    Zylber-Katz E; Granit L; Stessman J; Levy M
    Eur J Clin Pharmacol; 1989; 36(5):513-6. PubMed ID: 2753071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation and excretion of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1992; 42(2):187-91. PubMed ID: 1618251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y; Zylber-Katz E; Granit L; Levy M
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kinetics of dipyrone metabolites in rapid and slow acetylators.
    Levy M; Flusser D; Zylber-Katz E; Granit L
    Eur J Clin Pharmacol; 1984; 27(4):453-8. PubMed ID: 6519153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
    Levy M; Safadi R; Zylber-Katz E; Granit L; Caraco Y
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):461-5. PubMed ID: 11699610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of dipyrone in man; role of the administration route.
    Asmardi G; Jamali F
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):121-5. PubMed ID: 4043141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatography of dipyrone and its active metabolite in biological fluids.
    Asmardi G; Jamali F
    J Chromatogr; 1983 Oct; 277():183-9. PubMed ID: 6643604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of dipyrone metabolite 4-MAA in the horse and possible implications for doping control.
    Klaus AM; Schlingloff Y; Kleinitz U; Böttcher M; Hapke HJ
    J Vet Pharmacol Ther; 1997 Jun; 20(3):204-8. PubMed ID: 9185086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of food on the pharmacokinetics of dipyrone.
    Flusser D; Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1988; 34(1):105-7. PubMed ID: 3360045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.
    Cohen O; Zylber-Katz E; Caraco Y; Granit L; Levy M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):549-53. PubMed ID: 9832297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.
    Neddermann E; Rohdewald P
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):105-11. PubMed ID: 3208789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited-sampling strategy models for estimating the pharmacokinetic parameters of 4-methylaminoantipyrine, an active metabolite of dipyrone.
    Suarez-Kurtz G; Ribeiro FM; Estrela RC; Vicente FL; Struchiner CJ
    Braz J Med Biol Res; 2001 Nov; 34(11):1475-85. PubMed ID: 11668360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of two metamizole (dipyrone) solutions as single doses of 2 g versus metamizole capsules.
    Artaza MA; Puerta JL; Ortiz R; Laporte JR
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):322-6. PubMed ID: 12139210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1985; 29(1):67-71. PubMed ID: 4054207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.
    Vlahov V; Badian M; Verho M; Bacracheva N
    Eur J Clin Pharmacol; 1990; 38(1):61-5. PubMed ID: 2328750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of dipyrone and its metabolites.
    Levy M; Zylber-Katz E; Rosenkranz B
    Clin Pharmacokinet; 1995 Mar; 28(3):216-34. PubMed ID: 7758252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dipyrone, acetylsalicylic acid and acetaminophen on human neutrophil chemotaxis.
    Matzner Y; Drexler R; Levy M
    Eur J Clin Invest; 1984 Dec; 14(6):440-3. PubMed ID: 6441720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on HPLC method for determination of 4-methylaminoantipyrine and relative bioavailabilities of analgin nasal drops in human volunteers].
    Cui JB; Xi NZ; Jiang XG
    Yao Xue Xue Bao; 1997; 32(1):65-8. PubMed ID: 11243223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of dipyrone metabolites in human breast milk.
    Zylber-Katz E; Linder N; Granit L; Levy M
    Eur J Clin Pharmacol; 1986; 30(3):359-61. PubMed ID: 3732376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.